- Bevorzugter Name
- Glucose-conjugated MGMT inhibitor
- IUPAC
- 8-{2-Amino-6-[(4-bromothiophen-2-yl)methoxy]-9H-purin-9-yl}octyl beta-D-glucopyranoside
- Englischer Name
- (2R,3R,4S,5S,6R)-2-((8-(2-aMino-6-((4-broMothiophen-2-yl)Methoxy)-9H-purin-9-yl)octyl)oxy)-6-(hydroxyMethyl)tetrahydro-2H-pyran-3,4,5-triol
- Summenformel
- C24H34BrN5O7S
- Molmasse
- 616.53
Namen und Synonyme
O6BTG-C8-βGluO6BTG-octylglucosideGlucose-conjugated MGMT inhibitorO-6BTG-octylglucoside,O6BTG octylglucoside,O6BTGoctylglucosideβ-D-Glucopyranoside, 8-[2-aMino-6-[(4-broMo-2-thienyl)Methoxy]-9H-purin-9-yl]octyl8-[2-Amino-6-[(4-bromo-2-thienyl)methoxy]-9H-purin-9-yl]octyl beta-D-glucopyranoside(2R,3R,4S,5S,6R)-2-[8-[2-amino-6-[(4-bromothiophen-2-yl)methoxy]purin-9-yl]octoxy]-6-(hydroxymethyl)oxane-3,4,5-triol(2R,3R,4S,5S,6R)-2-((8-(2-aMino-6-((4-broMothiophen-2-yl)Methoxy)-9H-purin-9-yl)octyl)oxy)-6-(hydroxyMethyl)tetrahydro-2H-pyran-3,4,5-triol
Datenbank-Bezeichner
- PubChem CID
- 10438805
- DTXSID
DTXSID90439860- Nikkaji
- J1.604.406G